Multivariate analysis of CMV incidence after CB transplantation
Characteristic . | No. . | RR (95% CI) . | P . |
|---|---|---|---|
| Recipient pretransplantation CMV antibody | |||
| Negative | 634 | Reference | |
| Positive | 568 | 60 (4.0-8.5) | <.001 |
| Recipient age | |||
| 0-1 y | 246 | Reference | |
| 2-11 y | 564 | 1.0 (0.7-1.5) | .9 |
| 12 y or older | 392 | 1.2 (0.8-1.8) | .5 |
| Recipient ethnicity* | |||
| White | 678 | Reference | |
| Not white | 524 | 1.4 (1.06-1.9) | .017 |
| Transplant center location | |||
| United States | 954 | Reference | |
| Outside of United States | 248 | 1.6 (1.2-2.1) | .004 |
| Year of transplantation | |||
| 1993-1999 | 775 | Reference | |
| 2000-2004 | 427 | 1.5 (1.1-2.0) | .004 |
| HLA mismatch† | |||
| 0 | 67 | Reference | |
| 1 | 421 | 3.0 (1.3-6.9) | .011 |
| 2-3 | 714 | 2.8 (1.2-6.3) | .017 |
| Cord blood donor's maternal CMV antibody | |||
| IgG | 668 | 0.96 (0.7-1.3) | .8 |
| IgM | 42 | 1.4 (0.7-2.8) | .3 |
| Equivocal | 7 | 0.8 (0.2-3.2) | .7 |
| Negative | 485 | Reference |
Characteristic . | No. . | RR (95% CI) . | P . |
|---|---|---|---|
| Recipient pretransplantation CMV antibody | |||
| Negative | 634 | Reference | |
| Positive | 568 | 60 (4.0-8.5) | <.001 |
| Recipient age | |||
| 0-1 y | 246 | Reference | |
| 2-11 y | 564 | 1.0 (0.7-1.5) | .9 |
| 12 y or older | 392 | 1.2 (0.8-1.8) | .5 |
| Recipient ethnicity* | |||
| White | 678 | Reference | |
| Not white | 524 | 1.4 (1.06-1.9) | .017 |
| Transplant center location | |||
| United States | 954 | Reference | |
| Outside of United States | 248 | 1.6 (1.2-2.1) | .004 |
| Year of transplantation | |||
| 1993-1999 | 775 | Reference | |
| 2000-2004 | 427 | 1.5 (1.1-2.0) | .004 |
| HLA mismatch† | |||
| 0 | 67 | Reference | |
| 1 | 421 | 3.0 (1.3-6.9) | .011 |
| 2-3 | 714 | 2.8 (1.2-6.3) | .017 |
| Cord blood donor's maternal CMV antibody | |||
| IgG | 668 | 0.96 (0.7-1.3) | .8 |
| IgM | 42 | 1.4 (0.7-2.8) | .3 |
| Equivocal | 7 | 0.8 (0.2-3.2) | .7 |
| Negative | 485 | Reference |